J. David Gladstone Institutes President Robert W. Mahley, MD, PhD, today announced the appointment of Deepak Srivastava, MD, as the new director of the Gladstone Institute of Cardiovascular Disease (GICD).

UCSF's Mission Bay campus is now headquarters for a new center to advance research on membrane proteins – proteins that are on the outside surface of cells and are the targets of nearly half of all drugs.

The UCSF Osher Lifelong Learning Institute (OLLI) continues its second year this spring with a new course entitled "Preventive Health Care for Older Adults."

Nawang Sherpa, who last May became the first man with a prosthetic leg to summit Mount Everest, delivered hope to patients at UCSF recently.

The new J. David Gladstone Institutes research facility, located at Mission Bay, has been selected as the San Francisco Business Times 2004 Real Estate Deal of the Year Award as Best New Office R&D Development/San Francisco.

UCSF Professor Sally J. Marshall, PhD, has been appointed Associate Vice Chancellor of Academic Affairs, a key position that involves working to improve the quality of life for faculty.

The campus community is invited to hear what UCSF and organizations around the Bay Area are doing to protect the planet during an Earth Day fair on Wednesday, April 13.

A drug prescribed for the prevention of osteoporosis reduced women's risk of mild cognitive impairment by 33 percent in a worldwide clinical trial led by researchers at San Francisco VA Medical Center (SFVAMC).

A drug prescribed for the prevention of osteoporosis reduced women's risk of mild cognitive impairment by 33 percent in a worldwide clinical trial led by researchers at San Francisco VA Medical Center (SFVAMC).